PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1028
https://www.valueinhealthjournal.com/article/S1098-3015(19)33406-0/fulltext
Title :
PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33406-0&doi=10.1016/j.jval.2019.09.1028
First page :
Section Title :
Open access? :
No
Section Order :
10907